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Abstract 
Objective: To compare MRI patterns of cortical thinning in subjects with dementia with 
Lewy bodies (DLB), Alzheimer’s disease (AD) and normal ageing and investigate the 
relationship between cortical thickness and clinical measures. 
Methods: Study participants (31 DLB, 30 AD and 33 healthy comparison subjects) 
underwent 3 Tesla T1-weighted MRI and completed clinical and cognitive assessments. 
We used the FreeSurfer analysis package to measure cortical thickness and investigated 
the patterns of cortical thinning across groups.   
Results: Cortical thinning in AD was found predominantly in the temporal and parietal 
areas extending into the frontal lobes (n=63, df=59, t>3.3, p<0.005, FDR corrected). In 
DLB, cortical thinning was less diffuse with focal areas of cortical change predominantly 
affecting posterior structures (inferior parietal, posterior cingulate and fusiform gyrus) 
(n=64, df=60, t>3.6, p<0.005, FDR corrected). The average reduction in cortical 
thickness in medial temporal lobe structures was less in DLB (6-10%) than in AD (15-
24%), and similar to the reduction in cortical thickness observed in other regions 
including inferior parietal, precuneus and posterior cingulate (6-9%). Associations 
between cortical thickness and clinical measures (MMSE and verbal fluency) were also 
observed in DLB (n=31, df=27, t>2.8, p<0.01 uncorrected).  
Conclusion: Cortical thickness may be a sensitive measure for characterising grey matter 
loss in DLB and highlights important structural imaging differences between the 
conditions. 
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INTRODUCTION 
Dementia with Lewy bodies and Alzheimer’s disease (AD) are common forms of 
dementia yet the clinical separation between the conditions remains challenging. In vivo 
biomarkers are therefore required which can help differentiate between the conditions 
and improve our understanding of the clinical features observed. DLB and AD show 
some differences in regional structural atrophy on MRI with greater medial temporal lobe 
atrophy in AD. However, there are relatively few cortical differences observed despite 
marked differences seen with functional imaging. 
Imaging techniques and analysis methods are becoming increasingly sensitive thereby 
improving their potential as a diagnostic technique. Measurement of cortical thickness 
(CTh) is an advanced method of structural image analysis. It allows the regional 
distribution and quantification of cortical loss to be specifically examined which is in 
contrast to gyral or lobar volumetric studies which often combine grey matter and white 
matter within regional volumes. Voxel based morphometry (VBM) does allow separate 
grey matter assessment, although results have been shown to be more closely related to 
alterations in cortical surface area and folding (1, 2). Studies have investigated CTh in 
AD (3, 4) however, regional patterns of CTh have not yet been assessed in DLB. 
We aimed to investigate CTh in subjects with DLB compared to AD and similar aged 
healthy comparison subjects. We hypothesised that in AD, the pattern of cortical thinning 
would involve predominantly the temporal lobe, parietal association cortices and frontal 
regions. In contrast, the pattern of cortical thinning in DLB would be much less diffuse 
involving predominantly the posterior cortical structures. In an exploratory analysis, we 
investigated the association between CTh and clinical measures including MMSE, letter 
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fluency, visual hallucinations and UPDRS III. We hypothesised that areas of cortical 
thinning would be associated with poorer task performance and the tests would correlate 
with anatomical areas known to be necessary for their performance. 
 
METHODS 
Subjects, assessments and diagnosis 
Seventy-one individuals over the age of 60 (36 subjects with probable AD (5) and 35 
with probable DLB (6)) were recruited from a community dwelling population of patients 
referred to local Old Age Psychiatry, Geriatric Medicine or Neurology Services. All 
subjects underwent clinical and neuropsychological evaluations as previously 
described.(7) Thirty-five similar aged healthy subjects were recruited from among 
relatives and friends of subjects with dementia or volunteered via advertisements in local 
community newsletters.  
 
The research was approved by the local ethics committee. All subjects or, where 
appropriate, their nearest relative, provided written informed consent. 
Assessment of global cognitive measures in all subjects (AD, DLB and healthy subjects) 
included the Cambridge Cognitive Examination (CAMCOG) which incorporates the 
Mini-Mental State Examination (MMSE).(8) Motor parkinsonism was assessed with the 
Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III).(9) For subjects with 
dementia, neuropsychiatric features were assessed using the Neuropsychiatric Inventory 
(NPI)(10) and function was assessed using the Bristol Activities of Daily Living.(11) 
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MRI data acquisition 
Subjects underwent T1 weighted MR scanning on a 3T MRI system using an 8 channel 
head coil (Intera Achieva scanner, Philips Medical Systems, Eindhoven, Netherlands) 
within 2 months of the study assessment, as previously described.(7) The sequence was a 
standard T1 weighted volumetric sequence covering the whole brain (3D MPRAGE, 
sagittal acquisition, 1 mm isotropic resolution and matrix size of 240 (anterior-posterior) 
x 240 (superior-inferior) x 180 (right-left); repetition time (TR) = 9.6ms; echo time (TE) 
= 4.6ms; flip angle = 8
o
; SENSE factor = 2). The acquired volume was angulated such 
that the axial slice orientation was standardised to align with the AC-PC line. 
 
Imaging processing  
Estimates of CTh were performed from cortical surface reconstructions computed from 
T1w images using FreeSurfer (v. 4.5, http://surfer.nmr.mgh.harvard.edu/). The technical 
aspects of these methods have been described elsewhere.(12-14) In brief, the processing 
stream involves intensity non-uniformity correction, Talairach registration, removal of 
non-brain tissue (skull stripping), white matter (WM) and subcortical grey matter (GM) 
segmentation, tessellation of the GM-WM boundary then surface deformation following 
GM-CSF intensity gradients to optimally place GM-WM and GM-CSF borders.(12, 13) 
Once cortical models were generated, surface inflation, transformation to a spherical atlas 
and parcellation of the cerebral cortex into regions based on gyral and sulcal structure 
were carried out.(15) This technique used both intensity and continuity information from 
the entire 3D MR volume in the segmentation and deformation procedures to produce 
representations of CTh, calculated as the closest distance from the GM-WM to GM-CSF 
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boundaries at each vertex on the tessellated surface.(16) CTh measures were mapped to 
the inflated surface. All images were then aligned to a common surface template and 
smoothed with a 20mm full width at half maximum (FWHM) surface based Gaussian 
kernel.  
 
Visual inspection of images at each step of the FreeSurfer processing stream was 
carefully carried out to ensure accurate Talairach transformations, skull strips, deep GM 
and white/pial surface generation and tissue classifications. During this procedure, skull 
strips and pial/WM surface errors were identified in 27 scans (6 healthy subjects, 13 AD, 
8 DLB). In these subjects, a different skull stripping algorithm was applied using a brain 
masking approach prior to reapplication of the FreeSurfer processing stream (less skull 
stripping). This involved segmentation of the MR scan into GM, WM and cerebrospinal 
fluid (CSF) using the standard unified segmentation model in SPM8 
(http://www.fil.ion.ucl.ac.uk/spm).(17) The segmented images were combined and 
thresholded to create individual brain mask images that were then applied to the original 
T1w scan, producing the skull stripped image. Modification to the processing stream 
resulted in successful cortical surface generation in 15 scans (4 healthy subjects, 7 AD, 4 
DLB). However, the remaining 12 scans (2 healthy subjects, 6 AD, 4 DLB), still 
exhibited significant pial/WM surface errors and were therefore excluded (5F, 7M; mean 
age 80.2 (5.62); MMSE (AD, DLB) = 19.0 (4.34)). The dataset for subsequent CTh 
analysis comprised of 33 comparison subjects, 30 AD and 31 DLB.  
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Statistical analysis 
The Statistical Package for Social Sciences software (SPSS ver. 19.0.0.1, http://www-
01.ibm.com/software/analytics/spss/) was used for further statistical evaluation as 
required. Continuous variables were tested for normality using the Shapiro-Wilk test and 
visual inspection of histograms. Where appropriate, differences in demographic and 
clinical data were assessed using parametric (ANOVA, t-tests) and non-parametric tests 
(Kruskall-Wallis H, Mann-Whitney U). For categorical measures, χ2 tests were applied. 
For each test statistic, a probability value of <0.05 was regarded as significant.  
 
Cortical thickness 
Regional CTh between groups were examined on a vertex-wise basis using the general 
linear model (GLM), performed with the QDEC software 
(http://surfer.nmr.mgh.harvard.edu/fswiki/Qdec).  CTh was modelled as a function of 
group, controlling for effects of age and gender as nuisance covariates. CTh = β1 Group1 
+ β2 Group2 + β3 Age + β4 Gender + μ + ε (where μ is a constant and ε is error). Contrasts 
of interest were calculated using two-tailed t-tests between the group estimates β1 and β2 
which represent either DLB vs. healthy older subjects, AD vs. healthy older subjects or 
DLB vs. AD. Surface maps showing significant differences between groups were 
generated. Effects of CTh on clinical variables (MMSE, letter fluency, visual 
hallucinations and UPDRS III) were also investigated in DLB and AD. CTh was 
modelled as a function of covariate of interest, controlling for effects of age and gender 
as nuisance covariates. CTh = β1 Behavioural variable + β2 Age + β3 Gender + μ + ε. 
Contrasts of interest were calculated from the estimate β1, and whether β1 was 
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significantly different from zero. Similarly, surface maps were created demonstrating 
significant behavioural correlates on CTh. For all statistical analyses, surface maps were 
presented as either corrected (false discovery rate approach (FDR) (18)) or uncorrected 
probabilities. 
 
As well as surface maps, FreeSurfer also generated thickness measures from 33 cortical 
regions of interest for each hemisphere as described by Desikan et al.(15) 
 
RESULTS 
Subject characteristics 
The demographic data for patients and healthy subjects are summarised in Table 1. 
Subject groups were well matched for age and, for the AD and DLB groups mean 
CAMCOG and MMSE scores were similar. There were more men in the DLB group and 
as expected, the DLB group had significantly higher UPDRS III scores than the AD and 
healthy comparison group. 
 
Comparison of AD and healthy subjects 
The areas of cortical thinning in AD compared to healthy older individuals are 
represented in Figure 1 (a), (n=63, df=59, t>3.3, p<0.005, FDR corrected) and Table 2 
(b). In AD, cortical thinning was diffuse and involved the temporal, parietal and frontal 
lobes. The most significant areas affected were, the entorhinal cortex and 
parahippocampal gyrus with an average reduction of 23-24% and 15-16% respectively 
when compared to healthy subjects (Table 3).  
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Comparison of DLB and healthy subjects 
The areas of cortical thinning in DLB compared to healthy subjects are represented in 
Figure 1 (b), (n=64, df=60, t>3.6, p<0.005, FDR corrected) and Table 2 (a). In DLB, 
there was generally less cortical thinning than observed in AD compared to healthy 
subjects. There was a large cluster in the left inferior parietal area and smaller clusters in 
the left superior temporal and the left anterior and posterior cingulate. There were large 
clusters of significant cortical thinning observed in the right fusiform and right superior 
temporal gyri. Smaller clusters were found in the inferior parietal and superior temporal 
gyri and the right posterior cingulate.  
 
Comparison of AD and DLB 
When comparing AD and DLB, areas of significant thinning (n=61, df=57, t>4.1, p<0.05, 
FDR corrected) were located in the left medial temporal lobe structures – entorhinal 
cortex and parahippocampal gyri. 
 
Cortical thickness in AD and DLB using the Desikan parcellation map  
The average CTh reduction in AD and DLB compared to healthy older individuals using 
FreeSurfer Desikan parcellation regions of interest were also reviewed. Results for 
selected regions are represented in Table 3. In AD, reduction in CTh was diffuse and the 
medial temporal lobe structures were most affected (15-24% reduction) followed by the 
inferior parietal, precuneus and posterior cingulate (5-10% reduction). In DLB, the 
average cortical thinning in the medial temporal lobe structures was less (6-10% 
reduction) than for AD and similar to the reduction in cortical thickness observed in other 
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regions. The percentage reduction in CTh in the inferior parietal, precuneus and posterior 
cingulate (5-9%) were similar to that observed in AD. In DLB, the transverse temporal 
gyri and right precentral gyri were areas that had more cortical thinning compared with 
healthy subjects than observed in AD. 
 
Cortical thickness and cognitive and clinical measures 
In DLB subjects there was a positive association between MMSE and CTh in the left 
superior frontal, superior temporal and parahippocampal gyri and right posterior 
cingulate, insula and fusiform gyri (Figure 2 (a); n=31, df=27, t>2.8, p<0.01 
uncorrected). We did not find an association between MMSE and CTh in AD (n=30, 
df=26, t<2.1, p>0.05 uncorrected). Performance on letter fluency also positively 
correlated with CTh in the left precuneus, precentral, superior frontal (anterior cingulate), 
lingual and postcentral gyri and right fusiform, precuneus, lateral orbitofrontal and 
inferior parietal in DLB (n=31, df=27, t>2.8, p<0.01 uncorrected). These associations are 
represented in Figure 2 (b). We did not find an association between cortical thickness and 
letter fluency performance in AD (n=30, df=26, t<2.1, p>0.05 uncorrected). 
 
DISCUSSION 
Patterns of cortical thinning differed in DLB and AD when compared to a group of 
similarly aged older subjects. AD was characterised by cortical thinning in the medial 
temporal and temporo-parietal association cortices as well as areas of the frontal cortices. 
DLB was characterised by more localised areas of cortical thinning predominantly 
affecting the posterior parietal cortices with relative sparing of the frontal and medial 
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temporal structures. Correlations between MMSE and verbal fluency and CTh in DLB 
were also observed in key cortical regions. 
 
In DLB, there was localised cortical thinning in the posterior parietal association cortices. 
Functional imaging studies using SPECT have reported precuneal and occipital 
hypoperfusion.(19, 20) However, structural imaging studies have not consistently 
reported change.(21, 22) We have previously reported the results of structural change in 
this cohort using VBM analysis and visual rating scales.(7, 23) Whilst there was a pattern 
suggestive of posterior atrophy using VBM, it did not reach statistical significance when 
corrected for multiple comparisons (high probability of false positives) and using a visual 
rating scale there was no significant difference when compared to either healthy 
individuals or AD.(7, 23) By contrast, a pattern of highly significant white matter tract 
change in the parieto-occipital areas was observed using diffusion tensor imaging.(24) 
Cortical thinning in DLB may be a result of secondary grey matter loss following white 
matter tract degeneration, or vice versa. Further studies using multimodal analysis 
techniques and longitudinal assessment may help to address this. It may also be that 
measurements of cortical thickness are a more sensitive means for studying regional 
patterns of grey matter atrophy.  The inferior longitudinal fasciculus connects the 
occipital lobe to the temporal pole and runs in the inferior temporal gyri, hypothesised to 
form the ventral visual stream, with the temporal pole also receiving input from the 
anterior cingulate via the uncinate fasciculus. We observed focal areas of cortical 
thinning in the temporal pole and lateral temporal structures, areas that have also been 
reported to be associated with Lewy related pathology and visual hallucinations.(25) We 
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also found cortical thinning in the posterior cingulate with the average loss similar to 
Alzheimer’s disease. The posterior cingulate forms the central node of the default mode 
network and receives input from the thalamus, an important structure for attentional 
function with projections to the precuneus. The posterior cingulate in DLB has also been 
found to be vulnerable to amyloid deposition using PET with amyloid burden being 
associated with visuo-spatial dysfunction.(26) Our findings of cortical thinning in this 
region highlight the posterior cingulate as an area of vulnerability and importance in the 
pathogenesis of DLB.  
 
The medial temporal structures were profoundly affected in AD. In particular the 
entorhinal cortex and parahippocampal gyri had the most extensive cortical loss. As 
expected, there was much less cortical thinning observed in these regions in DLB which 
is consistent with other imaging (7, 22) and pathological studies (27, 28) as well as the 
relative sparing (when compared to AD) of episodic memory observed.(29) Interestingly, 
the average percentage cortical loss in the medial temporal structures in DLB was similar 
to other (lateral) temporal and parietal regions. Whilst, it is possible that the medial 
temporal atrophy observed may be due to Alzheimer pathology, the differential gradient 
suggests that other pathophysiological mechanisms may be contributing.  
 
We found a positive association between cortical thickness measures in temporal 
structures including fusiform, insula and superior temporal gyrus, the right posterior 
cingulate and left superior frontal and MMSE. Therefore, in DLB subjects, cortical 
thinning in these regions appeared to be associated with greater disease severity as 
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measured by the MMSE. Although these results need to be interpreted with the important 
caveat that they are reported uncorrected for multiple comparisons (increased Type I 
error). This association was not observed in AD, which may, in part be due to floor 
effects as in AD many of these structures are affected early and more profoundly. Given 
the groups were of similar level of dementia severity, it suggests that there are differing 
pathophysiological mechanisms underpinning the global cognitive changes in DLB and 
AD.  
 
We also found a positive association between letter fluency and CTh in the frontal and 
parietal structures in DLB and not AD. This indicates that subjects with greater cortical 
thinning in these regions were more likely to perform poorly on the letter fluency task. 
Generally patients with DLB are characterised by a dysexecutive syndrome with the 
fronto-striatal network being implicated (29). However, functional imaging studies 
indicate that input from the temporal and parietal association cortices are also required 
(30). The precuneus is an important and potentially vulnerable structure in DLB as 
demonstrated in functional imaging studies (19). The association between CTh in this 
region and more impaired verbal fluency suggests its clinical importance in the 
pathogenesis of DLB and how it differs to AD. 
 
Cortical thickness measurement using MRI may be a more sensitive measure of structural 
grey matter change. It offers novel insights into important structural imaging differences 
between the conditions. Interestingly, a recent logistic regression study of pathologically 
confirmed cases using selected regions on antemortem structural MRI found excellent 
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diagnostic sensitivity in DLB, highlighting the potential for structural MRI measures as a 
useful biomarker in distinguishing between the conditions.(31) Others have also reported 
excellent diagnostic sensitivity in DLB when combining multi-modal imaging variables 
from PiB-PET, FDG-PET and structural MRI in DLB and AD.(32)  At this stage, the 
clinical and treatment implications of cortical thickness measurement are somewhat 
limited and further studies are required to address the potential diagnostic utility. 
Furthermore, the analysis procedures involved in the technique also currently limit its 
clinical utility. However, improved computational systems and machine learning 
techniques using computer based classification methods would assist the development of 
this as a clinically useful investigation and warrants further investigation and 
development.  
 
Strengths of the study include a well-characterised group of probable DLB and AD 
patients. In addition, the healthy comparison group were well matched for age and 
educational level. Subject groups were based on clinical rather than pathological 
confirmation, a limitation of all ante-mortem imaging studies. In addition, it is likely that 
a proportion of healthy subjects will also have preclinical disease which would 
potentially reduce the reported difference. During the FreeSurfer processing we had an 
11% failure rate, similar to other groups. The inclusion of 2 T1 weighted scans has been 
suggested to improve this and may be a consideration for future work.  
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Cortical thickness may be a sensitive measure for characterising grey matter atrophy in 
DLB and highlights the structural imaging differences between the conditions. It may 
have a valuable role in distinguishing groups, although requires further investigation. 
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Table 1. Demographic and group characteristics. 
 
Values expressed as Mean  1SD. 
 
Post Hoc Mann-Whitney U tests: 
 
†
HS > AD (U63=47.9, p<0.001), HS > DLB (U64=42.6, p<0.001), AD vs. DLB (U61=5.3, p=1.0). 
††
 HS > AD (U63=50.0, p<0.001), HS > DLB (U64=43.0, p<0.001), AD vs. DLB (U61=4.9, p=1.0). 
†††
 HS > AD (U63=17.0, p=0.04), HS > DLB (U64=54.1, p<0.001), AD vs. DLB (U61=37.1, p<0.001). 
 
Abbreviations: DLB, dementia with Lewy bodies; AD, Alzheimer’s disease; HS, Healthy subjects; MMSE, 
Mini-Mental State examination; CAMCOG, Cambridge Cognitive Examination; UPDRS III, Unified 
Parkinson’s Disease Rating Scale, Part III. 
 
 
 
  
  
Healthy subjects 
 
DLB 
 
AD 
 
p value 
     
    
 
n 33 31 30  
Gender (m: f) 19: 14 26: 5 16: 14 χ2=7.4, 0.02 
Age (year) 76.8  5.3 77.8  7.1 77.9  5.7 F2,91=0.35, p=0.71 
MMSE 29.0  1.0 20.6  5.1 19.5  4.7 H2=59.9, p<0.001
†
 
CAMCOG  97.0  3.7 68.3  15.1 65.5  11.4 H2=60.0, p<0.001
††
 
UPDRS III 2.0  1.9 26.0  10.3 5.6  4.5 H2=65.7, p<0.001
†††
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Table 2. Location and peak vertex significance of cortical thinning in DLB (two-sample t-test, 
df=60) and AD (two-sample t-test, df=59) compared to healthy older subjects. For each peak, 
table shows anatomical region, Brodmann area, Talairach coordinates, Number of vertices (Vtx), 
Surface area (Area) (mm
2
), vertex-level significance (PFDR-Corr). All results are significant 
p<0.005, False Discovery Rate (FDR) corrected (e.g., -log10P = 3 corresponds to p=0.001…etc). 
BA=Brodmann area, Vtx=Number of Vertices, Area=surface Area.  
 
 
 BA x y z Vtx Area -log10P 
(a) Healthy subjects vs. DLB       
Left medial orbitofrontal 11 -8 30 -16 206 133 3.77 
Left superior frontal 8 -7 26 44 235 142 3.75 
Left superior temporal 22 -51 -6 -7 1353 751 4.09 
Left inferior temporal 36 -48 -41 -22 1018 636 5.21 
Left temporal pole 38 -35 13 -34 418 235 3.91 
Left fusiform 37 -34 -43 -9 503 229 4.36 
Left superior parietal 7 -31 -56 60 1055 434 4.46 
Left inferior parietal 19 -38 -82 26 7594 4135 6.50 
Left posterior cingulate 7 -7 -33 41 1052 444 5.68 
Right superior frontal 9 9 31 34 467 245 4.47 
Right superior temporal 38 43 11 -26 3813 2024 6.49 
Right middle temporal 21 56 -57 7.1 835 425 5.09 
Right fusiform 37 37 -43 -11 1790 882 6.84 
Right precuneus 19 20 -78 36 1085 678 4.38 
Right superior parietal 7 13 -65 60 106 45 3.68 
Right inferior parietal 40 55 -52 35 510 255 4.04 
Right posterior cingulate 24 5 -22 39 509 221 4.23 
(b)  Healthy subjects vs. AD       
Left medial orbitofrontal 11 -8 25 -14 903 486 3.90 
Left superior frontal 32 -20 19 57 4666 2771 3.62 
Left paracentral 5 -5 -42 65 525 228 3.11 
Left entorhinal 35 -20 -14 -27 53805 26764 11.88 
Right superior frontal 6 10 28 35 2159 1140 5.12 
Right entorhinal 28 21 -13 -27 54043 27651 9.18 
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Table 3. Cortical thickness (CTh) in selected brain regions in AD and DLB. Average cortical 
thickness derived from the Desikan template is expressed in mm (Mean  1 SD). CTh% = 
difference in the average cortical thickness (in AD and DLB) compared to the healthy comparison 
group, expressed as a percentage reduction. 
 
 
  
 
 
AD 
 
DLB 
AD 
CTh % 
DLB 
CTh % 
 
Left precentral gyrus 2.24  0.28 2.26  0.19 6.0 4.9 
Left entorhinal cortex 2.38  0.42 2.89  0.45 23.4 7.3 
Left parahippocampal gyrus 2.10  0.25 2.32  0.35 15.5 6.7 
Left transverse temporal 2.19  0.24 2.07  0.29 3.6 8.6 
Left inferior parietal 2.22  0.13 2.28  0.22 10.5 8.3 
Left precuneus 2.16  0.19 2.23  0.17 8.3 5.5 
Left posterior cingulate 2.33  0.26 2.30  0.17 5.3 6.6 
Right precentral gyrus 2.28  0.23 2.21  0.20 3.8 6.8 
Right entorhinal cortex 2.43  0.53 2.87  0.49 23.6 9.7 
Right parahippocampal gyrus 2.09  0.35 2.29  0.27 16.4 8.3 
Right transverse temporal  2.25  0.28 2.13  0.24 2.0 7.3 
Right inferior parietal 2.25  0.22 2.26  0.18 7.8 7.6 
Right posterior cingulate  2.26  0.23 2.27  0.15 5.2 4.8 
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Figure 1. Patterns of cortical thinning across groups. Significantly thinner cortex in patients with 
(A) Alzheimer’s disease compared to healthy older individuals (two-sample t-test, df=59), (B) 
dementia with Lewy bodies compared to healthy older individuals (two-sample t-test, df=60) and 
(C) Alzheimer’s disease compared to dementia with Lewy bodies (two-sample t-test, df=57). 
Areas of significant cortical thinning are represented in red/orange/yellow as indicated by the 
coloured bar (False Discovery Rate corrected p values). 
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Figure 2. Correlation between cortical thickness (CTh) and clinical features in DLB. Relationship 
between CTh and MMSE score (a) and Verbal (letter) Fluency (b) (linear regressions, df=27). 
Graphical representation of the CTh measurement and clinical variable in selected regions are 
also displayed. LH, left hemisphere; RH, right hemisphere; CTh, cortical thickness; MMSE, 
mini-mental state examination. Results shown are uncorrected p values. 
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